Bimatoprost for Eyelash Growth in Japanese Subjects: Two Multicenter Controlled Studies

Authors:

Abstract
Bimatoprost 0.03 % has enhanced eyelash prominence in clinical trials enrolling mostly Caucasian subjects. The studies described in this report evaluated the efficacy and safety of bimatoprost in Japanese subjects with idiopathic and chemotherapy-induced eyelash hypotrichosis.

This publication has 25 references indexed in Scilit: